[LGND] QoQ Quarter Result on 30-Sep-2010 [#Q3]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
09-Nov-2010
Financial Year
2010
Quarter
30-Sep-2010 [#Q3]
Profit Trend
QoQ- -4,084.81%
YoY- -756.85%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 CAGR
Revenue 7,463 3,896 3,940 7,802 5,838 5,958 13,977 -34.25%
PBT -773 -4,292 -1,587 -11,436 335 -2,715 1,034 -
Tax 141 -13,778 -3,935 419 625 274 -1,535 -
NP -914 9,625 4,503 -11,843 -283 -2,750 3,036 -
Tax Rate - - - - -186.57% - 148.45% -
Total Cost 8,377 -5,729 -563 19,645 6,121 8,708 10,941 -16.34%
Ratio Analysis
30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 CAGR
NP Margin -12.25 247.05 114.29 -151.79 -4.85 -46.16 21.72 -
Per Share
30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 CAGR
EPS -0.05 0.49 0.23 -0.60 -0.01 -0.14 0.16 -
EPS Diluted -0.05 0.49 0.23 -0.60 -0.01 -0.14 0.16 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.